Tech Healthcare Sector

Interpharm Holdings

Market Cap: US$66.0

Develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals.

North Bud Farms

Market Cap: US$66.0

Through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada.

Capha Pharmaceuticals

Market Cap: US$64.0

Does not have significant operations.

Dermisonics

Market Cap: US$63.0

Manufactures ultrasonic transdermal drug-delivery technologies and equipment.

Sunnylife Global

Market Cap: US$63.0

Owns and operates hospitals in China.

IMRIS

Market Cap: US$62.0

Designs, manufactures, and sells image-guided therapy solutions worldwide.

Avisa Diagnostics

Market Cap: US$59.0

Operates a clinical-stage medical device company.

Frélii

Market Cap: US$58.0

Provides personalized subscription based nutrition and wellness programs.

Inyx

Market Cap: US$53.0

Through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe.

Panacos Pharmaceuticals

Market Cap: US$53.0

A development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases.

Orchid Ventures

Market Cap: US$52.0

Engages in the design, development, manufacturing, branding, and distribution of cannabis vape products in North America.

Baudax Bio

Market Cap: US$52.0

A pharmaceutical company, develops and commercializes products for hospital and other acute care related settings.

Optima Medical Innovations

Market Cap: US$47.0

Optima Medical Innovations Corp. delivers pathways to innovative, science-based health, and wellness solutions.

Callitas Health

Market Cap: US$45.0

Provides over the counter consumer health and wellness products in the United States and Canada.

Mymetics

Market Cap: US$45.0

Engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland.

Ember Therapeutics

Market Cap: US$43.0

Operates as a clinical stage biopharmaceutical company.

9342-8530 Québec

Market Cap: US$43.0

9342-8530 Québec Inc., a life sciences company, develops and commercializes products relating to the diagnosis of cancer in Canada.

US BioTec

Market Cap: US$41.0

Engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States.

Skylight Health Group

Market Cap: US$41.0

Operates as a healthcare services and technology company in the United States.

MedLink International

Market Cap: US$40.0

Engages in selling, implementing, and supporting software solutions that provide physician practices, laboratories, and other healthcare organizations access to clinical, administrative, and financial data.

NewCardio

Market Cap: US$40.0

A cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development.

Integrative Health Technologies

Market Cap: US$40.0

Provides fee-based clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries.

Response Genetics

Market Cap: US$38.0

A life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally.

Canntab Therapeutics

Market Cap: US$38.0

A phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada.

Miravant Medical Technologies

Market Cap: US$37.0

Operates as a pharmaceutical research and development company.

Claritas Pharmaceuticals

Market Cap: US$37.0

A clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs.

Goodbody Health

Market Cap: US$36.0

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

WellQuest Medical & Wellness

Market Cap: US$35.0

Provides an integrated medical delivery site with family physician healthcare, preventive/wellness, and medical skin-care services.

DermTech

Market Cap: US$35.0

A molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States.

Aspyra

Market Cap: US$34.0

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces.

ARYx Therapeutics

Market Cap: US$33.0

ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets.

Deltagen

Market Cap: US$32.0

Provides drug discovery tools and services to the biopharmaceutical industry.

Monarch Staffing

Market Cap: US$30.0

Provides healthcare staffing services to healthcare providers, state institutions, and related organizations in California.

LifeHOUSE Holdings

Market Cap: US$30.0

Operates senior assisted and independent living, and skilled nursing facilities in the United States.

Targeted Medical Pharma

Market Cap: US$29.0

A specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States.

Lombard Medical

Market Cap: US$27.0

Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally.